SEC Form 4 · accession 0000939767-17-000147
EXELIXIS, INC. · EXEL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Morrissey
Officer — President and CEO · Director
Period of report
Sep 12, 2017
Accepted (ET)
Sep 14, 2017 · 7:14 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000939767
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Sep 12, 2017 | M | 100,000 | $1.70 | A | 160,000 | D | |
| Common StockF2 | Sep 12, 2017 | S | 100,000 | $26.59 | D | 60,000 | D | |
| Common Stock | Sep 13, 2017 | M | 100,000 | $1.70 | A | 160,000 | D | |
| Common StockF3 | Sep 13, 2017 | S | 100,000 | $27.04 | D | 60,000 | D | |
| Common Stock | Sep 14, 2017 | M | 100,000 | $1.70 | A | 160,000 | D | |
| Common StockF4 | Sep 14, 2017 | S | 100,000 | $27.08 | D | 60,000 | D | |
| Common StockF5 | holding | — | — | — | 172,698 | I | By Trust | |
| Common StockF6 | holding | — | — | — | 17,020 | I | By 401(k) |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option (right to buy)F7 | $1.70 | Sep 12, 2017 | M | 100,000 | D | Jul 20, 2015 | Sep 18, 2021 | Common Stock | 100,000 | 1,004,551 | D |
| Option (right to buy)F7 | $1.70 | Sep 13, 2017 | M | 100,000 | D | Jul 20, 2015 | Sep 18, 2021 | Common Stock | 100,000 | 904,551 | D |
| Option (right to buy)F7 | $1.70 | Sep 14, 2017 | M | 100,000 | D | Jul 20, 2015 | Sep 18, 2021 | Common Stock | 100,000 | 804,551 | D |
Explanation of responses
- F1Includes 60,000 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.
- F2Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $26.44 to $26.70. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4
- F3Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $26.90 to $27.35. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4
- F4Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $26.97 to $27.20. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 4 to this Form 4
- F5Shares held by Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Living Trust dated July 21, 1994, as amended.
- F6Represents 17,020 shares of Exelixis, Inc. common stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of September 12, 2017.
- F7The option, representing the right to purchase a total of 1,125,000 shares of Exelixis, Inc. common stock, became exercisable as to fifty percent (50%) of the shares subject to the option on July 20, 2015, as to twenty-five (25%) of the shares subject to the option on March 7, 2016 and as to the remaining twenty-five (25%) of the shares subject to the option on April 28, 2016.